Clinical Trial Update: A Clinical Study of MK-8527 to Prevent Human Immunodeficiency Virus Type 1 (HIV-1) (MK-8527-011) [Phase 3]

View source ↗

Summary

This is a Phase 3 clinical trial update for MK-8527 evaluating its ability to prevent HIV-1 infection (HIV pre-exposure prophylaxis). The study is currently rec…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• MK-8527

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Human Immunodeficiency Virus (HIV), HIV Pre-Exposure Prophylaxis | Phase 3 | Status: RECRUITING